Stock Events

Stock Events

BioGaia 

€11.02
0
+€0+0% Friday 06:00

Statistics

Day High
11.02
Day Low
11.02
52W High
11.2
52W Low
8.53
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
0.07
0.08
0.08
0.09
Expected EPS
0.069983916249336
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGLA.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Daiichi Sankyo.
DSKYF
Mkt Cap31.93B
Danisco (DuPont Nutrition & Biosciences) offers probiotic strains that compete directly with BioGaia's products in the dietary supplement market.
Chervon Limited
CHRHF
Mkt Cap1.21B
Chr. Hansen Holding A/S specializes in probiotic and natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries, directly competing with BioGaia's probiotic offerings.
Novonesis AS
NVZMY
Mkt Cap28.23B
Novozymes provides bioinnovation, including probiotics that can be used in various applications, competing in the same space as BioGaia.
Kerry Group
KRYAF
Mkt Cap12.19B
Kerry Group offers nutritional and functional ingredients, including probiotics, that compete with BioGaia's range of products.
Herbalife
HLF
Mkt Cap1.57B
Herbalife Nutrition offers dietary supplements, including probiotics, competing in the same market as BioGaia.
Nusatrip
NUTR
Mkt Cap174.41M
Nutraceutical International Corporation manufactures and markets nutritional supplements, including probiotics, directly competing with BioGaia.
Amarin
AMRN
Mkt Cap301.24M
Amarin Corporation focuses on cardiovascular health products, but its interest in overall health could lead to expansion into areas like probiotics, making it a potential competitor to BioGaia.

About

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.
Show more...
CEO
Ms. Theresa P. Agnew
Employees
224
Country
United States
ISIN
SE0017769995

Listings

OTC Link
US
BIOGY
STU
DE
BGLA.STU
MU
DE
BGLA.MU
F
DE
BGLA.F

0 Comments

Share your thoughts

FAQ

What is BioGaia stock price today?▼
The current price of BGLA.MU is €11.02 EUR — it has increased by +0% in the past 24 hours. Watch BioGaia stock price performance more closely on the chart.
What is BioGaia stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioGaia stocks are traded under the ticker BGLA.MU.
When is the next BioGaia earnings date?▼
BioGaia is going to release the next earnings report on May 07, 2026.
What were BioGaia earnings last quarter?▼
BGLA.MU earnings for the last quarter are 0.09 EUR per share, whereas the estimation was 0.07 EUR resulting in a +22.5% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does BioGaia have?▼
As of April 13, 2026, the company has 224 employees.
In which sector is BioGaia located?▼
BioGaia operates in the Health & Wellness sector.
When did BioGaia complete a stock split?▼
BioGaia has not had any recent stock splits.
Where is BioGaia headquartered?▼
BioGaia is headquartered in Stockholm, United States.